Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Testicular Neoplasms 1Klinefelter Syndrome 1Infertility 1Hypogonadism 1

Interventions

Etoposide 22Carboplatin 22Filgrastim 17Ifosfamide 15Cisplatin 14Peripheral Blood Stem Cell Transplantation 12Paclitaxel 12Cyclophosphamide 9Bleomycin 9Thiotepa 5Radiotherapy 5Therapeutics 4Temozolomide 4Psychiatric Rehabilitation 4Oxaliplatin 4Melphalan 4Granulocyte Colony-Stimulating Factor 4Gemcitabine 4sargramostim 3pegfilgrastim 3etoposide phosphate 3Methylprednisolone 3Dexamethasone 3Busulfan 3liposomal amphotericin B 2ixabepilone 2aldesleukin 2aflibercept 2Trastuzumab 2Topotecan 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Testicular Neoplasms × Castor Oil × Clear all
NCT01206270 2018-09-25

ALCeP

University of Roma La Sapienza

Phase 2/3 Completed
56 enrolled
Genitourinary

Hypogonadism, Infertility, Klinefelter Syndrome, Testicular Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡